N/LP Ratio as Predictor of Mortality in Septic AKI Patients

NCT05559086 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-10-04

No results posted yet for this study

Summary

To evaluate the role of Neutrophils to lymphocytes and platelets ratio (N/LP ratio) as a biomarkers for mortality in septic -AKI

Conditions

  • Acute Kidney Injury Due to Sepsis

Sponsors & Collaborators

  • Mahmoud Kamel Mohamed Abd elhaq

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-25
Primary Completion
2024-02-25
Completion
2025-03-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05559086 on ClinicalTrials.gov